Page Banner

United States Department of Agriculture

Agricultural Research Service

Title: Biosafety, Serology, and Efficacy of Brucella Abortus Strain Rb51 in Cattle

Authors
item Olsen, Steven
item Palmer, Mitchell

Submitted to: International Congress on Anthrax, Brucellosis, CBPP, Mycobacterial Disease
Publication Type: Proceedings
Publication Acceptance Date: August 14, 1998
Publication Date: N/A

Technical Abstract: Brucella abortus strain RB51 is a new brucellosis vaccine for cattle that offers advantages over previously used vaccines. Strain RB51 has very low expression, or does not express, the lipopolysaccharide O-side chain. Calfhood or adult vaccination with strain RB51 does not induce antibody responses that cause positive responses on conventional brucellosis surveillance tests. Therefore, strain RB51 vaccination does not interfere with detection of cattle infected with field strains of B. abortus. Strain RB51 localizes in lymphatic tissues and does not cause significant histological lesions in any tissue. When administered subcutaneously to calves between 4 and 10 months of age, dosages of 10*10 colony-forming units (CFU) are cleared by most cattle within 12 weeks. When compared to nonvaccinated cattle, calfhood vaccination with 10*10 CFU of strain RB51 induces significant protection against abortion or infection following midgestational challenge with 10*7 CFU of virulent B. abortus strain 2308 Data from our studies suggest that calfhood vaccination with strain RB51 or B. abortus strain 19 induce similar levels of protection against abortion or infection.

Last Modified: 9/23/2014
Footer Content Back to Top of Page